Modulation of the association between plasma intercellular adhesion molecule-1 and cancer risk by n-3 PUFA intake: a nested case-control study

Mechanistic data suggest that n-3 PUFAs and endothelial function may interact and play a role in carcinogenesis, but epidemiologic evidence is lacking. Our objective was to investigate whether the prospective association between soluble intercellular adhesion molecule-1 (sICAM-1) and cancer risk is...

Full description

Saved in:
Bibliographic Details
Published inThe American journal of clinical nutrition Vol. 95; no. 4; pp. 944 - 950
Main Authors Touvier, Mathilde, Kesse-Guyot, Emmanuelle, Andreeva, Valentina A, Fezeu, Léopold, Charnaux, Nathalie, Sutton, Angela, Druesne-Pecollo, Nathalie, Hercberg, Serge, Galan, Pilar, Zelek, Laurent, Latino-Martel, Paule, Czernichow, Sébastien
Format Journal Article
LanguageEnglish
Published Bethesda, MD American Society for Nutrition 01.04.2012
American Society for Clinical Nutrition, Inc
Oxford University Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Mechanistic data suggest that n-3 PUFAs and endothelial function may interact and play a role in carcinogenesis, but epidemiologic evidence is lacking. Our objective was to investigate whether the prospective association between soluble intercellular adhesion molecule-1 (sICAM-1) and cancer risk is modulated by n-3 PUFA intake. A nested case-control study was designed to include all first-incident cancer cases diagnosed in the SUpplémentation en VItamines et Minéraux AntioXydants cohort between 1994 and 2007, with available dietary data from 24-h records (n = 408). Cases were matched with 1 or 2 randomly selected controls (n = 760). Conditional logistic regression was used to estimate ORs and 95% CIs for the association between prediagnostic plasma concentrations of sICAM-1 and cancer risk, stratified by n-3 PUFA intake. The interactions between sICAM-1 and n-3 PUFA intake were tested. An interaction was observed between sICAM-1 and n-3 PUFA intake, which was consistent across the studied cancer locations (P-interaction = 0.036 for overall, 0.038 for breast, and 0.020 for prostate cancer risk). sICAM-1 concentrations were positively associated with cancer risk among subjects with n-3 PUFA intakes below the median (multivariate OR(Tertile3vsTertile1): 2.8; 95% CI: 1.5, 5.2; P-trend = 0.001), whereas this association was not observed for subjects with n-3 PUFA intakes above the median (OR(Tertile3vsTertile1): 1.3; 95% CI: 0.8, 2.3; P-trend = 0.3). These findings suggest that n-3 PUFA intake may counteract the procarcinogenic actions of sICAM-1.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
ObjectType-Undefined-3
ISSN:0002-9165
1938-3207
1938-3207
DOI:10.3945/ajcn.111.027805